BASAL CELL CARCINOMA
Clinical trials for BASAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BASAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for BASAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for transplant patients with advanced skin cancer: RP1 trial launches
Disease control OngoingThis study tests a drug called RP1, which is injected directly into skin tumors, for people who have had an organ or stem cell transplant and now have advanced skin cancer. The goal is to see if RP1 can shrink tumors safely without harming the transplanted organ. About 69 partici…
Matched conditions: BASAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Replimune, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Immunotherapy duo takes on 50+ rare cancers in major trial
Disease control OngoingThis phase 2 trial tests a combination of two immunotherapy drugs (nivolumab and ipilimumab) in over 800 people with more than 50 types of rare cancers. The goal is to see if this treatment can shrink tumors by helping the immune system attack cancer cells. The study is for patie…
Matched conditions: BASAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Flash of hope: new Ultra-Fast radiation tested for skin cancer
Disease control OngoingThis study tests a new type of radiation therapy called FLASH, which delivers treatment in a fraction of a second, against standard radiotherapy for people with localized skin cancer (basal cell or squamous cell carcinoma). The goal is to see if FLASH causes fewer severe skin sid…
Matched conditions: BASAL CELL CARCINOMA
Phase: NA • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New injection shows promise for common skin cancer in early trial
Disease control OngoingThis study tests an experimental drug called BO-112, injected directly into basal cell skin cancer tumors before they are surgically removed. The goal is to see if the drug is safe and can shrink or eliminate the cancer. About 60 adults with low- or high-risk basal cell carcinoma…
Matched conditions: BASAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Highlight Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New imaging tech could make skin cancer radiation more precise
Disease control OngoingThis study tests whether a special camera (RCM/OCT) can help doctors aim radiation more precisely at basal cell carcinoma, a common skin cancer. About 38 adults with small to medium-sized tumors will receive radiation guided by this imaging. Researchers will check if the cancer i…
Matched conditions: BASAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:44 UTC
-
Smart laser zaps skin cancer with precision
Disease control OngoingThis study tests a new way to treat basal cell carcinoma, a common skin cancer. Doctors use a special imaging tool (OCT) to see the cancer clearly and then guide a laser to destroy it. The goal is to remove the cancer completely while causing less damage to healthy skin. About 40…
Matched conditions: BASAL CELL CARCINOMA
Phase: NA • Sponsor: Christopher Zachary • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
New combo therapy aims to turn tumors against themselves in advanced cancer patients
Disease control OngoingThis early-phase study tests whether a mix of drugs and targeted radiation can help the immune system recognize and attack hard-to-treat solid tumors. About 14 adults with advanced melanoma, breast cancer, or other solid cancers that cannot be surgically removed will receive inje…
Matched conditions: BASAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
No treatment, just observation: new study tracks skin cancer growth
Knowledge-focused OngoingThis study follows 26 adults with small basal cell carcinomas (a common skin cancer) for up to 3 years. Researchers use special cameras and imaging to measure how the tumors grow, without providing any treatment. The goal is to learn more about these cancers and find better ways …
Matched conditions: BASAL CELL CARCINOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 04:12 UTC